{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:29:07Z","timestamp":1784233747319,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Shanghai Science and Technology Committee","doi-asserted-by":"crossref","award":["12431900600"],"award-info":[{"award-number":["12431900600"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ejphar.2018.05.030","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T12:29:58Z","timestamp":1527078598000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl4-induced liver fibrosis in mice"],"prefix":"10.1016","volume":"833","author":[{"given":"Peng","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modrak Samantha","family":"Kristine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2018.05.030_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/lt.24129","article-title":"Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure","volume":"21","author":"Basta","year":"2015","journal-title":"Liver Transplant."},{"issue":"29","key":"10.1016\/j.ejphar.2018.05.030_bib2","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.3748\/wjg.v11.i29.4566","article-title":"Circulating adhesion molecules in patients with virus-related chronic diseases of the liver","volume":"11","author":"Bruno","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/hep.510310136","article-title":"Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond","volume":"31","author":"Brunt","year":"2000","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3892\/mmr.2014.2207","article-title":"Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis","volume":"10","author":"Cai","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0036-1597816","article-title":"Regression of liver fibrosis","volume":"37","author":"Campana","year":"2017","journal-title":"Semin Liver Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20040934","article-title":"RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB","volume":"201","author":"Cataldegirmen","year":"2005","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2014.07.035","article-title":"S100A4 promotes liver fibrosis via activation of hepatic stellate cells","volume":"62","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/156652413804486214","article-title":"Functions of S100 proteins","volume":"13","author":"Donato","year":"2013","journal-title":"Curr. Mol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3892\/ijo.2013.2231","article-title":"S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways","volume":"44","author":"Duan","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2018.05.030_bib10","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S1470-2045(05)70168-6","article-title":"The MAPK signalling pathways and colorectal cancer","volume":"6","author":"Fang","year":"2005","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2018.05.030_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1053\/jhep.2001.28788","article-title":"Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts","volume":"34","author":"Fehrenbach","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2009.12.007","article-title":"Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cells","volume":"52","author":"Guimaraes","year":"2010","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.21.1.63","article-title":"Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin","volume":"21","author":"Hahn","year":"1980","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pep.2012.03.002","article-title":"Expression and purification of bioactive high-purity human S100A6 in Escherichia coli","volume":"83","author":"He","year":"2012","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejphar.2018.05.030_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.ejphar.2018.05.030_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1572-0241.2004.04152.x","article-title":"Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma","volume":"99","author":"Hu","year":"2004","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.ajkd.2005.12.028","article-title":"Soluble receptor for advanced glycation end products in patients with decreased renal function","volume":"47","author":"Kalousova","year":"2006","journal-title":"Am. J. Kidney Dis."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1872-034X.2011.00776.x","article-title":"Evolution of hepatic fibrosis research","volume":"41","author":"Kawada","year":"2011","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.030_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1053\/jhep.2000.9322","article-title":"Proteome analysis of rat hepatic stellate cells","volume":"32","author":"Kristensen","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ejphar.2018.05.030_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.bbamcr.2008.11.016","article-title":"Binding of S100 proteins to RAGE: an update","volume":"1793","author":"Leclerc","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"issue":"43","key":"10.1016\/j.ejphar.2018.05.030_bib21","doi-asserted-by":"crossref","first-page":"31317","DOI":"10.1074\/jbc.M703951200","article-title":"S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains","volume":"282","author":"Leclerc","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejphar.2018.05.030_bib22","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.bbrc.2009.10.150","article-title":"S100A6 - new facts and features","volume":"390","author":"Lesniak","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ejphar.2018.05.030_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jmb.2006.04.009","article-title":"Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity","volume":"359","author":"Leukert","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/mc.22563","article-title":"S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38\/MAPK signaling pathway","volume":"56","author":"Li","year":"2017","journal-title":"Mol. Carcinog."},{"issue":"12","key":"10.1016\/j.ejphar.2018.05.030_bib25","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/jcmm.12419","article-title":"Emerging role of HMGB1 in fibrotic diseases","volume":"18","author":"Li","year":"2014","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2018.05.030_bib26","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00109-013-1104-3","article-title":"Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma","volume":"92","author":"Li","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"6","key":"10.1016\/j.ejphar.2018.05.030_bib27","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1159\/000438591","article-title":"The calcium-binding protein S100A6 accelerates human osteosarcoma growth by promoting cell proliferation and inhibiting osteogenic differentiation","volume":"37","author":"Li","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.030_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004738","article-title":"Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion","volume":"6","author":"Mofid","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ejphar.2018.05.030_bib29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2220\/biomedres.35.351","article-title":"Serum expression of S100A6 is a potential detection marker in patients with urothelial carcinoma in the urinary bladder","volume":"35","author":"Nishi","year":"2014","journal-title":"Biomed. Res-Tokyo"},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbrc.2006.04.077","article-title":"Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris","volume":"347","author":"Ostendorp","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2018.05.030_bib31","article-title":"Molecular mechanisms of hepatic fibrogenesis","volume":"22","author":"Parsons","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.ejphar.2018.05.030_bib32","doi-asserted-by":"crossref","first-page":"16R","DOI":"10.1093\/glycob\/cwi053","article-title":"Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation","volume":"15","author":"Ramasamy","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.ejphar.2018.05.030_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-7-17","article-title":"RAGE (receptor for advanced glycation endproducts), RAGE ligands, and their role in cancer and inflammation","volume":"7","author":"Sparvero","year":"2009","journal-title":"J. Transl. Med."},{"issue":"5363","key":"10.1016\/j.ejphar.2018.05.030_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1126\/science.280.5363.599","article-title":"Activation of the protein kinase p38 in the spindle assembly checkpoint and mitotic arrest","volume":"280","author":"Takenaka","year":"1998","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ejphar.2018.05.030_bib35","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1007\/s00125-006-0394-1","article-title":"Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes","volume":"49","author":"Tan","year":"2006","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.ejphar.2018.05.030_bib36","doi-asserted-by":"crossref","first-page":"12710","DOI":"10.1074\/jbc.M111598200","article-title":"ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently ofp53","volume":"277","author":"Tang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.030_bib37","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s13277-015-4057-z","article-title":"Diagnostic significance of S100A2 and S100A6 levels in sera of patients with non-small cell lung cancer","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.ejphar.2018.05.030_bib38","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3892\/ol.2016.5419","article-title":"Increased expression of S100A6 promotes cell proliferation in gastric cancer cells","volume":"13","author":"Wang","year":"2017","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.ejphar.2018.05.030_bib39","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0168-8278(00)80363-3","article-title":"Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride","volume":"33","author":"Watanabe","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.05.030_bib40","first-page":"99","article-title":"Isolation and culture of hepatic stellate cells","volume":"117","author":"Weiskirchen","year":"2005","journal-title":"Methods Mol. Med."},{"issue":"4","key":"10.1016\/j.ejphar.2018.05.030_bib41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/ijms9040638","article-title":"Specific siRNA targeting the receptor for advanced glycation end products inhibits experimental hepatic fibrosis in rats","volume":"9","author":"Xia","year":"2008","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2018.05.030_bib42","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2016.03.017","article-title":"Therapeutic effects of antigen affinity-purified polyclonal anti-receptor of advanced glycation end-product (RAGE) antibodies on cholestasis-induced liver injury in rats","volume":"779","author":"Xia","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.05.030_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9583268","article-title":"Signaling pathways in cardiac myocyte apoptosis","author":"Xia","year":"2016","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ejphar.2018.05.030_bib44","article-title":"Production of bioactive recombinant rat soluble receptor for advanced glycation end products (rrsRAGE) in Pichia pastoris","author":"Xia","year":"2015","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ejphar.2018.05.030_bib45","article-title":"Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B","author":"Yan","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"12","key":"10.1016\/j.ejphar.2018.05.030_bib46","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.str.2016.09.011","article-title":"The Structure of the RAGE:S100A6 Complex Reveals a Unique Mode of Homodimerization for S100 Proteins","volume":"24","author":"Yatime","year":"2016","journal-title":"Structure"},{"issue":"9","key":"10.1016\/j.ejphar.2018.05.030_bib47","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s10620-014-3137-z","article-title":"S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer","volume":"59","author":"Zhang","year":"2014","journal-title":"Dig. Dis. Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918302929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T12:16:18Z","timestamp":1538396178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918302929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":47,"alternative-id":["S0014299918302929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl4-induced liver fibrosis in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}